Tecovirimat is Safe But Did Not Improve Clade I Mpox Resolution in Democratic Republic of the Congo
Tecovirimat did not improve clade I mpox resolution in DRC, but showed safe use and lower mortality. Ongoing trials like PALM007 and STOMP aim to develop effective mpox interventions.
Related Clinical Trials
Highlighted Terms
NCT05559099Institut National de Recherche BiomédicaleU.S. Department of Health and Human ServicesNational Institute of Allergy and Infectious DiseasesKinshasa University Medical SchoolLeidos Biomedical ResearchNCT05534984National Institutes of HealthWorld Health OrganizationDemocratic Republic of the CongoInstitute of Tropical Medicine AntwerpTecovirimatFood and Drug AdministrationSIGA Technologies, Inc.NCT05597735mpoxAlliance for International Medical ActionFrederick National Laboratory for Cancer ResearchCenters for Disease Control and Prevention
Related News
Tecovirimat is Safe But Did Not Improve Clade I Mpox Resolution in Democratic Republic of the Congo
Tecovirimat did not improve clade I mpox resolution in DRC, but showed safe use and lower mortality. Ongoing trials like PALM007 and STOMP aim to develop effective mpox interventions.